Key facts
- It has raised $1.6M; the latest was Early Stage VC ($1.6M) in May 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Lumati
- ·The full record, as it builds
Funding rounds
No funding rounds for Lumati are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lumati
Developer of a personalized health optimization platform designed to enhance vitality and longevity through a multi-modal approach. The company offers a combination of advanced diagnostics, integrated therapies, and real-time coaching, enabling individuals seeking to improve their well-being to achieve efficient, science-backed results with minimal time investment.
- Sector
- Healthcare
- HQ
- Encinitas, CA, United States
- Founded
- 2022
- Employees
- 18
- Website
- lumati.com/
- Ownership
- Privately Held (backing)
Lumati doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lumati shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lumati in its N-PORT filings yet. We sweep new filings monthly.